Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma
Clinical trial NCT01429025 · COMPLETED
Trial details
- NCT number
- NCT01429025
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.